VPAC2 agonists (Longevity)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVPAC2 agonists (Longevity)
Drug Alias NameVasoactive intestinal peptide receptor 2 agonists (Longevity)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVasoactive intestinal polypeptide receptor 2 agonists
TargetsVasoactive intestinal polypeptide receptor 2
Therapy Area/IndicationsHypertensionParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLongevity Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLongevity Biotech
Active IndicationsN/A
Inactive IndicationsHypertensionParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A